Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Economics of Acromegaly Treatment in Brazil: A Budget Impact Analysis of Pituitary Surgery Compared with Long-Term Octreotide LAR.

Porto LB, Zimmermann IR, Naves LA.

Pharmacoecon Open. 2018 Nov 2. doi: 10.1007/s41669-018-0103-2. [Epub ahead of print]

2.

Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan.

Bolt T, Kobayashi H, Mahlich J.

Pharmacoecon Open. 2018 Oct 30. doi: 10.1007/s41669-018-0104-1. [Epub ahead of print]

3.

Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials.

Porter JK, Di Tanna GL, Lipton RB, Sapra S, Villa G.

Pharmacoecon Open. 2018 Oct 30. doi: 10.1007/s41669-018-0105-0. [Epub ahead of print]

4.

Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation.

South E, Cox E, Meader N, Woolacott N, Griffin S.

Pharmacoecon Open. 2018 Oct 17. doi: 10.1007/s41669-018-0102-3. [Epub ahead of print] Review.

5.

Working with Patients and Members of the Public: Informing Health Economics in Child Health Research.

Kandiyali R, Hawton A, Cabral C, Mytton J, Shilling V, Morris C, Ingram J.

Pharmacoecon Open. 2018 Oct 15. doi: 10.1007/s41669-018-0099-7. [Epub ahead of print]

6.

Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain.

Boluda B, Rodríguez-Veiga R, Martínez-Cuadrón D, Lorenzo I, Sanz J, Regadera A, Sempere A, Senent L, Cervera JV, Solves P, Reitan J, Gea S, Sanz MA, Montesinos P.

Pharmacoecon Open. 2018 Oct 15. doi: 10.1007/s41669-018-0098-8. [Epub ahead of print]

7.

Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States.

Bell JA, Galaznik A, Blazer M, Shih HC, Farrelly E, Ogbonnaya A, Eaddy M, Fram RJ, Faller DV.

Pharmacoecon Open. 2018 Oct 15. doi: 10.1007/s41669-018-0100-5. [Epub ahead of print]

8.

Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research.

Buchanan J, Wordsworth S.

Pharmacoecon Open. 2018 Oct 4. doi: 10.1007/s41669-018-0101-4. [Epub ahead of print] No abstract available.

9.

Correction to: Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes.

Sohrt A, Mærkedahl A, Padula WV.

Pharmacoecon Open. 2018 Sep 19. doi: 10.1007/s41669-018-0095-y. [Epub ahead of print]

10.

Does Structured Exercise Improve Cognitive Impairment in People with Mild to Moderate Dementia? A Cost-Effectiveness Analysis from a Confirmatory Randomised Controlled Trial: The Dementia and Physical Activity (DAPA) Trial.

Khan I, Petrou S, Khan K, Mistry D, Lall R, Sheehan B, Lamb S; DAPA Trial Group.

Pharmacoecon Open. 2018 Sep 11. doi: 10.1007/s41669-018-0097-9. [Epub ahead of print]

11.

Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England.

Lee D, Amadi A, Sabater J, Ellis J, Johnson H, Kotapati S, McNamara S, Walker A, Cooper M, Patterson K, Roskell N, Meng Y.

Pharmacoecon Open. 2018 Sep 11. doi: 10.1007/s41669-018-0096-x. [Epub ahead of print]

12.

Value Assessment Frameworks in the United States: A Call for Patient Engagement.

Diaby V, Ali AA, Montero AJ.

Pharmacoecon Open. 2018 Sep 4. doi: 10.1007/s41669-018-0094-z. [Epub ahead of print] No abstract available.

13.

High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids' Inpatient Database (KID).

Cardenas J, Menier M, Heitzer MD, Sproule DM.

Pharmacoecon Open. 2018 Sep 4. doi: 10.1007/s41669-018-0093-0. [Epub ahead of print]

14.

The Psychometric Properties of a Self-Administered, Open-Source Module for Valuing Metastatic Epidural Spinal Cord Compression Utilities.

Pahuta M, Frombach A, Hashem E, Spence S, Sun C, Wai EK, Werier J, van Walraven C, Coyle D.

Pharmacoecon Open. 2018 Sep 3. doi: 10.1007/s41669-018-0092-1. [Epub ahead of print]

15.

Cost Comparison of Single-Use Versus Reusable Bronchoscopes Used for Percutaneous Dilatational Tracheostomy.

Sohrt A, Ehlers L, Udsen FW, Mærkedahl A, McGrath BA.

Pharmacoecon Open. 2018 Aug 30. doi: 10.1007/s41669-018-0091-2. [Epub ahead of print]

16.

Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes.

Sohrt A, Mærkedahl A, Padula WV.

Pharmacoecon Open. 2018 Aug 27. doi: 10.1007/s41669-018-0090-3. [Epub ahead of print] Erratum in: Pharmacoecon Open. 2018 Sep 19;:.

17.

Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate.

Emond B, Joshi K, Khoury ACE, Lafeuille MH, Pilon D, Tandon N, Romdhani H, Lefebvre P.

Pharmacoecon Open. 2018 Aug 7. doi: 10.1007/s41669-018-0089-9. [Epub ahead of print]

18.

International HTA Experience with Targeted Therapy Approvals for Lung Cancer.

Maraiki F, Byrnes J, Tuffaha H, Hinder M.

Pharmacoecon Open. 2018 Aug 3. doi: 10.1007/s41669-018-0088-x. [Epub ahead of print]

19.

Measuring the Benefits of Decision Aids for Economic Evaluation.

Butt T.

Pharmacoecon Open. 2018 Aug 1. doi: 10.1007/s41669-018-0087-y. [Epub ahead of print]

20.

Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations.

Shen J, Hill S, Mott D, Breckons M, Vale L, Pickard R.

Pharmacoecon Open. 2018 Jun 15. doi: 10.1007/s41669-018-0084-1. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center